Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...
Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
Anxiety disorders are characterized by “chronically elevated arousal.” This state floods the brain with stress-related ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
PureHealth Research announces their collection of supplements for nervous system support, designed for biohackers, executives, and wellness optimizers seeking to maintain peak cognitive and physical ...
Pharmaceutical Technology on MSN
Biogen’s Tysabri to be used on England’s NHS for highly active MS
NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple ...
Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...
Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.
Background We sought to identify an optimal oral corticosteroid regimen at the onset of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), which would delay time to first relapse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback